Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab: Predictive Value of Sarcopenia in mRCC. Radiol Oncol. 2025;59(4):624-634. Accessed October 1, 2026. https://www.radioloncol.com/index.php/ro/article/view/4685